Micropulse Transscleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma

Autor: Brett Mcknight, Vikas Chopra, Christine V. Nguyen, James C. Tan, Brian A. Francis, Giancarlo A. Garcia, Aleksandr Yelenskiy, Kenneth Lu, Alex S. Huang, Goichi Akiyama
Rok vydání: 2019
Předmět:
Zdroj: Ophthalmology Glaucoma. 2:402-412
ISSN: 2589-4196
DOI: 10.1016/j.ogla.2019.08.009
Popis: Purpose To assess the short-term efficacy and safety of micropulse transscleral diode laser cyclophotocoagulation (MP-TSCPC) in the management of refractory glaucoma and to compare outcomes based on prior glaucoma surgeries. Design Retrospective analysis. Participants Patients with refractory glaucoma who underwent MP-TSCPC at a single institution by 1 of 4 surgeons. Methods Chart review of cases of MP-TSCPC using the Iridex Cyclo G6 (Mountain View, CA) laser with standard parameters and laser duration at the discretion of each treating physician. Main Outcome Measures Probability of postoperative success was estimated by the Kaplan-Meier method. Success parameters included intraocular pressure (IOP) 6 to 21 mmHg with or without topical antihypertensive therapy, 20% or more IOP reduction from baseline for any 2 consecutive visits after 3 postoperative months, and no subsequent glaucoma surgery. Results One hundred sixteen eyes of 116 patients (mean age, 65.8±16.9 years) were included. Baseline IOP was 22.2±7.9 mmHg, and mean postoperative follow-up time was 6.3±3.4 months (range, 3–12 months.) Postoperative IOP at the final follow up was 15.3±6.6 mmHg (P Conclusions Micropulse transscleral diode laser cyclophotocoagulation has a significant short-term ocular hypotensive effect and favorable safety profile in eyes with refractory glaucoma. The probability of successful outcome was greater in eyes that had undergone prior traditional glaucoma surgery.
Databáze: OpenAIRE